BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38724221)

  • 1. Psychometric analysis of the modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) in a prospective multicentre study.
    Smith A; Greenwood D; Horton M; Osborne T; Goodwin M; Lawrence RR; Winch D; Williams P; Milne R; ; Sivan M
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38724221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric properties and observational data for COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) for post-COVID-19 syndrome.
    Kustura L; Bobek D; Poljičanin A; Pavelin S; Buljubašić Šoda M; Šoda J; Aksentijević J; Duka Glavor K; Narančić Knez N; Viali V; Cukrov A; Todorić Laidlaw I; Ipavec N; Vukorepa D; Stipica I; Bakrač K; Bošković B; Mastelić A; Režić Mužinić N; Markotić A; Đogaš Z; Dolić K; Rogić Vidaković M
    QJM; 2024 Feb; 117(1):38-47. PubMed ID: 37788123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for Long Covid or Post-COVID-19 syndrome.
    Sivan M; Preston N; Parkin A; Makower S; Gee J; Ross D; Tarrant R; Davison J; Halpin S; O'Connor RJ; Horton M
    J Med Virol; 2022 Sep; 94(9):4253-4264. PubMed ID: 35603810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COVID-19 Yorkshire Rehabilitation Scale (C19-YRS): Application and psychometric analysis in a post-COVID-19 syndrome cohort.
    O'Connor RJ; Preston N; Parkin A; Makower S; Ross D; Gee J; Halpin SJ; Horton M; Sivan M
    J Med Virol; 2022 Mar; 94(3):1027-1034. PubMed ID: 34676578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness.
    Bilbao A; García-Pérez L; Arenaza JC; García I; Ariza-Cardiel G; Trujillo-Martín E; Forjaz MJ; Martín-Fernández J
    Qual Life Res; 2018 Nov; 27(11):2897-2908. PubMed ID: 29978346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the Spanish version of the EuroQol-5D-5L in previously hospitalized COVID-19 survivors with long COVID.
    Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Moro-López-Menchero P; Cancela-Cilleruelo I; Pardo-Hernández A; Hernández-Barrera V; Gil-de-Miguel Á
    Sci Rep; 2022 Jul; 12(1):12605. PubMed ID: 35871259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study).
    Jauregui I; Gimenez-Arnau A; Bartra J; Labrador-Horrillo M; de Frutos JO; Silvestre JF; Sastre J; Velasco M; Ferrer M; Ballesteros C; Valero A
    Health Qual Life Outcomes; 2019 Jan; 17(1):23. PubMed ID: 30704532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The feasibility, repeatability, validity and responsiveness of the EQ-5D-3L in Krio for patients with stroke in Sierra Leone.
    Youkee D; Pessima S; Sackley C; Soley-Bori M; Deen GF; Marshall IJ
    Health Qual Life Outcomes; 2024 Mar; 22(1):29. PubMed ID: 38549069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity, responsiveness, and minimal clinically important difference of EQ-5D-5L in stroke patients undergoing rehabilitation.
    Chen P; Lin KC; Liing RJ; Wu CY; Chen CL; Chang KC
    Qual Life Res; 2016 Jun; 25(6):1585-96. PubMed ID: 26714699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Thai version of the COVID-19 Yorkshire Rehabilitation Scale: a valid instrument for the psychometric assessment of the community members in Bangkok, Thailand.
    Partiprajak S; Krongthaeo S; Piaseu N; Wongsathikun J; Kongsuwan A
    BMC Public Health; 2023 Apr; 23(1):663. PubMed ID: 37041552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric validation of the Psoriasis Symptom Scale, Functional Assessment of Chronic Illness Therapy-Fatigue and pain-Visual Analogue Scale in patients with generalized pustular psoriasis.
    Burden AD; Bissonnette R; Anatchkova M; Budhiarso I; Skalicky AM; Liberato ACS; Hu N; Thoma C; Gloede T; Kohlmann T; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2024 Jul; 38(7):1383-1390. PubMed ID: 38334243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiff cardiac ablation patient-reported outcome measure (C-CAP): validation of a new questionnaire set for patients undergoing catheter ablation for cardiac arrhythmias in the UK.
    White J; Withers KL; Lencioni M; Carolan-Rees G; Wilkes AR; Wood KA; Patrick H; Cunningham D; Griffith M
    Qual Life Res; 2016 Jun; 25(6):1571-83. PubMed ID: 26659900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric properties of the COVID-19 Yorkshire Rehabilitation Scale: Post-Covid-19 syndrome in Iranian elderly population.
    Tamadoni N; Bakhtiari A; Nikbakht HA
    BMC Infect Dis; 2024 Jan; 24(1):77. PubMed ID: 38212717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A brief, patient- and proxy-reported outcome measure in advanced illness: Validity, reliability and responsiveness of the Integrated Palliative care Outcome Scale (IPOS).
    Murtagh FE; Ramsenthaler C; Firth A; Groeneveld EI; Lovell N; Simon ST; Denzel J; Guo P; Bernhardt F; Schildmann E; van Oorschot B; Hodiamont F; Streitwieser S; Higginson IJ; Bausewein C
    Palliat Med; 2019 Sep; 33(8):1045-1057. PubMed ID: 31185804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation and multicentre validation of a patient-centred outcome scale for people severely ill with COVID (IPOS-COV).
    Hocaoglu MB; Murtagh FEM; Walshe C; Chambers RL; Maddocks M; Sleeman KE; Oluyase AO; Dunleavy L; Bradshaw A; Bajwah S; Fraser LK; Preston N; Higginson IJ;
    Health Qual Life Outcomes; 2023 Mar; 21(1):29. PubMed ID: 36964550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Psychometric Quality of EQ-5D-5L Scale for Assessing Health-Related Quality of Life of Malaria Patients.
    Jimam NS; Ismail NE; Dayom WD
    Value Health Reg Issues; 2020 Sep; 22():15-22. PubMed ID: 32007751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital Patient Reported Outcome Measures Platform for Post-COVID-19 Condition and Other Long-Term Conditions: User-Centered Development and Technical Description.
    Sivan M; Rocha Lawrence R; O'Brien P
    JMIR Hum Factors; 2023 Oct; 10():e48632. PubMed ID: 37665334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards patient-centred cancer care: cross-cultural validity and responsiveness of the Turkish Integrated Palliative care Outcome Scale.
    Hocaoglu MB; Hepgul N; Tunnard I; Meltem E; Efe H; Ataoglu B; Baybar YL; Kınacıgil M; Elsharairi H; Higginson IJ
    Health Qual Life Outcomes; 2020 Sep; 18(1):312. PubMed ID: 32962717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: a cohort study.
    Kuan WC; Chee KH; Kasim S; Lim KK; Dujaili JA; Lee KK; Teoh SL
    J Med Econ; 2024; 27(1):607-617. PubMed ID: 38557412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients.
    Degboe A; Ivanescu C; Rohay JM; Turner RR; Cella D
    Support Care Cancer; 2019 Nov; 27(11):4189-4198. PubMed ID: 30825026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.